医学
恩扎鲁胺
药代动力学
前列腺癌
不利影响
内科学
胃肠病学
前列腺特异性抗原
临床终点
紫杉烷
药理学
泌尿科
肿瘤科
癌症
临床试验
乳腺癌
雄激素受体
作者
Johann S. de Bono,Mark T. Fleming,Judy S. Wang,Richard Cathomas,Manuel Selvi Miralles,John Bothos,Mary Jane Hinrichs,Qu Zhang,Peng He,Marna Williams,Anton I. Rosenbaum,Meina Liang,Kapil Vashisht,Song Cho,Pablo Martínez,Daniel P. Petrylak
标识
DOI:10.1158/1078-0432.ccr-20-4528
摘要
Following dose escalation, no MTD was identified. Clinical responses occurred at higher doses, but were not durable as patients had to discontinue treatment due to TRAEs.
科研通智能强力驱动
Strongly Powered by AbleSci AI